Poging GOUD - Vrij
How Space Medicine Is Rewriting Healthcare
BioSpectrum Asia
|BioSpectrum Asia June 2026
Long considered the stuff of science fiction, space medicine is rapidly becoming a reality.
The field has been back in the spotlight this year with growing activity around the world. In April 2026, NASA's Artemis II mission carried AVATAR (A Virtual Astronaut Tissue Analog Response), an investigation that used organ-on-a-chip devices to study the effects of deep space radiation and microgravity on human health. Closer to home, China launched new in-orbit experimental projects in the same month as part of its broader ambitions for a space hospital. Across Asia Pacific, there are also growing collaborations and research efforts aimed at understanding how the human body behaves beyond Earth. What are the latest developments in space medicine across the region, and why does exploring space matter at all? Let's find out.
As space missions become longer and human spaceflight programmes expand, countries across Asia Pacific are increasing efforts in space medicine research. India, China, Japan, Australia and South Korea are studying how space conditions affect human biology. The goal is not only to support future missions beyond Earth, but also to apply these findings to healthcare on Earth.
India, with its growing space exploration ambitions, is also expanding its focus on space medicine. In March 2026, the Indian Space Research Organisation (ISRO) and All India Institute of Medical Sciences (AIIMS) signed a memorandum of understanding to promote research aligned with ISRO's priorities, with a focus on advancing human health, performance and safety during space missions. Earlier, in December 2025, ISRO and Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) entered into a partnership supporting the Gaganyaan programme through studies on physiological and behavioural changes in space, radiation exposure, biomedical systems, telemedicine and astronaut medical technologies. SCTIMST also launched a Space Medicine Centre and a Bioastronautics Fellowship in November 2025, expanding research and training efforts in the field.
Dit verhaal komt uit de BioSpectrum Asia June 2026-editie van BioSpectrum Asia.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN BioSpectrum Asia
BioSpectrum Asia
Malaysia, Thailand implement medical device reliance programme after successful pilot
The Medical Device Authority (MDA) of Malaysia and the Thai Food and Drug Administration (Thai FDA) signed a Confidentiality Agreement to deepen regulatory cooperation and officially launched a 3-month pilot of the Medical Device Regulatory Reliance Programme as part of the agreement.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Strand Life Sciences launches South Asia's first Olink Explore HT Proteomics Service
India-based Strand Life Sciences, a subsidiary of Reliance Industries Limited, has announced the launch of its advanced proteomics capabilities powered by Olink Explore HT, marking a key milestone in expanding largescale multi-omics research in South Asia.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
UK transforms mental healthcare with new strategy
Frontline workers, clinicians and mental health experts are being invited to share their views on how to transform mental healthcare for children and adults in England, as the government launches a call for evidence to shape its once-in-a-generation crossgovernment mental health strategy.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Australia Budget 2026-27: Investing in Care, Health and Innovation.
The Australian Federal Budget 2026-27, presented by the Albanese Government, places strong emphasis on healthcare, aged care, T disability services, research, innovation and social equality.
4 mins
BioSpectrum Asia June 2026
BioSpectrum Asia
Gavi proposes new incentives for advancing vaccine manufacturing in Africa
With Gavi's African Vaccine Manufacturing Accelerator (AVMA) expected to make its first cash disbursement to an African vaccine manufacturer in the second half of 2026, Gavi, the Vaccine Alliance has proposed further measures totaling $189 million of additional investment to further aid development of Africa's vaccine manufacturing sector.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
New WHO online course strengthens good practices in clinical trials
High-quality clinical trials are essential for generating reliable evidence to inform health policy, clinical practice and public trust in science.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
World Bank approves $225 M to improve healthcare in Côte d'Ivoire
The World Bank has approved $225 million in financing to help Côte d'Ivoire improve the delivery of quality health, nutrition, and early childhood development services for millions of people, particularly for women, children, and vulnerable households.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Nona Biosciences appoints Dr Josh Xiao as CSO
Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, has announced the appointment of Dr Josh Xiao as Chief Scientific Officer (CSO). Dr Xiao will be based in both the US and China and report directly to Dr Di Hong, Chief Executive Officer of Nona Biosciences.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Korea lays focus on stabilising medical product supply
The Ministry of Health and Welfare (MoHW), South Korea government, recently held its 7th meeting with healthcare and pharmaceutical associations, bringing together the Ministry of Trade, Industry and Resources (MOTIR), and the Ministry of Food and Drug Safety (MFDS).
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Formosa Pharma partners with SERI to advance novel ophthalmic formulations for corneal diseases
Taiwan-based Formosa Pharmaceuticals, Inc. and the Singapore Eye Research Institute (SERI) have announced a strategic research collaboration to develop next-generation ophthalmic formulations.
1 min
BioSpectrum Asia June 2026
Listen
Translate
Change font size

